SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes
SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. The company utilizes its proprietary Protein Splicing platform to develop next-generation gene therapies, particularly for conditions like Stargardt disease.